R.E.W. (Bob) Hancock OC, OBC, FRSC. A Professor of Microbiology & Immunology at the University of British Columbia, Vancouver Canada, and a Canada Research Chair in Health and Genomics, his research interests include small cationic peptides as novel antimicrobials and modulators of innate immunity, the development of novel treatments for antibiotic resistant infections, the systems biology of innate immunity and Pseudomonas aeruginosa, and antibiotic uptake and resistance. He has published more than 570 papers and reviews, has 42 patents awarded, and is an ISI highly cited author in microbiology with more than 30,000 citations. He has won several awards including the Aventis Pharmaceuticals Award, the leading award for antimicrobials research, and Canada’s three top prizes for Health Research, and is an Officer of the Order of Canada.